Documentos presentados ante la SEC (Comisión del mercado de valores) y otros informes de SAB Biotherapeutics, Inc.
Socio de datos
Descripción
Reported date
Formato
2025
Q2 2025
Ago 07, 2025
Earnings release8-K
Quarterly report10-Q
Q1 2025
Mayo 08, 2025
Earnings release8-K
Quarterly report10-Q
Oppenheimer 35th Annual Healthcare Life Sciences Conference 2025
Feb 12, 2025
Transcript
Guggenheim SMID Cap Biotech Conference
Feb 06, 2025
Transcript
2024
Q4 2024
Mar 30, 2025
Earnings release8-K
Annual report10-K
Corporate Presentation
Nov 19, 2024
Slides
Q3 2024
Nov 06, 2024
Earnings release8-K
Study Update
Sep 09, 2024
Press release
Slides
Q2 2024
Ago 08, 2024
Earnings release8-K
Quarterly report10-Q
Q1 2024
Mayo 20, 2024
Earnings release8-K
Quarterly report10-Q
2023
Q4 2023
Mar 29, 2024
Earnings release8-K
Q3 2023
Nov 14, 2023
Earnings release8-K
Quarterly report10-Q
Q2 2023
Ago 21, 2023
Earnings release8-K
Quarterly report10-Q
Study Update
Jun 22, 2023
Press release
Slides
Q1 2023
Mayo 16, 2023
Earnings release8-K
Quarterly report10-Q
Corporate Presentation
Mayo 03, 2023
Press release
Slides
2022
Q4 2022
Mar 31, 2023
Earnings release8-K
Q3 2022
Nov 15, 2022
Earnings release8-K
Quarterly report10-Q
Study Result
Nov 03, 2022
Press release
Slides
Investor Presentation
Oct 04, 2022
Slides
R&D Portfolio Update 2022
Ago 17, 2022
Slides
Q2 2022
Ago 10, 2022
Earnings release8-K
Quarterly report10-Q
Study Result
Jun 07, 2022
Slides
Q1 2022
Mayo 12, 2022
Earnings release8-K
2021
Q4 2021
Mar 29, 2022
Earnings release8-K
Q3 2021
Nov 22, 2021
Earnings release8-K
Quarterly report10-Q
R&D Day 2021
Oct 13, 2021
Slides